HIP
IDNA icon

HUB Investment Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

HUB Investment Partners’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,622
Closed -$286K – 648
2024
Q4 		$286K Sell
12,622
-3,392
-21% -$81.4K 0.01% 416
2024
Q3 		$394K Sell
16,014
-1,070
-6% -$26.1K 0.02% 334
2024
Q2 		$395K Sell
17,084
-266
-2% -$6.23K 0.02% 320
2024
Q1 		$418K Sell
17,350
-141
-0.8% -$3.31K 0.02% 310
2023
Q4 		$402K Sell
17,491
-3,938
-18% -$79.1K 0.03% 267
2023
Q3 		$436K Sell
21,429
-701
-3% -$15.7K 0.07% 154
2023
Q2 		$517K Buy
22,130
+1,350
+6% +$32.4K 0.09% 131
2023
Q1 		$484K Sell
20,780
-2,307
-10% -$57.7K 0.1% 125
2022
Q4 		$581K Sell
23,087
-1,458
-6% -$39.2K 0.13% 76
2022
Q3 		$648K Sell
24,545
-799
-3% -$24.7K 0.2% 85
2022
Q2 		$732K Sell
25,344
-3,012
-11% -$89.9K 0.23% 87
2022
Q1 		$977K Sell
28,356
-6,963
-20% -$246K 0.23% 86
2021
Q4 		$1.55M Sell
35,319
-302
-0.8% -$14.3K 0.36% 71
2021
Q3 		$1.81M Buy
35,621
+6,105
+21% +$318K 0.43% 68
2021
Q2 		$1.54M Buy
29,516
+3,337
+13% +$157K 0.41% 65
2021
Q1 		$1.2M Buy
26,179
+13,341
+104% +$652K 0.35% 79
2020
Q4 		$500K Buy
+12,838
New +$554K 0.23% 94

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
CCA
Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

HUB Investment Partners's IDNA Position: Q1 2025 in Review

HUB Investment Partners sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2025, closing a stake of 12,622 shares — an estimated $286K sold.

HUB Investment Partners first reported a position in IDNA in Q4 2020 and held it in 17 quarters. The position peaked at $1.81M in Q3 2021. 48 funds tracked by Wall St. Rank hold IDNA as of Q1 2025.

  • HUB Investment Partners reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2025 after selling out during the quarter.
  • HUB Investment Partners sold 12,622 iShares Genomics Immunology and Healthcare ETF shares in Q1 2025, an estimated $286K.
  • HUB Investment Partners first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 17 quarters.
  • HUB Investment Partners's iShares Genomics Immunology and Healthcare ETF position peaked at $1.81M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2025.

Based on HUB Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.